Santhera Pharmaceuticals Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santhera Pharmaceuticals Holding AG with three other
pharmaceutical manufacturers in Europe:
Science In Sport Plc
of the United Kingdom
sales of £15.62 million [US$19.62 million]
of which 89%
Vistin Pharma ASA
(176.69 million Norwegian Kroner [US$20.63 million]
Millet Innovation Sa
based in France
(21.44 million Euro [US$24.33 million]
of which 92%
was Pharmacies & Pharmaceutical Wholesale De).
During the year ended December of 2017, sales at
Santhera Pharmaceuticals Holding AG were 22.94 million Swiss Francs (US$23.17 million).
increase of 20.5%
versus 2016, when the company's sales were 19.03 million Swiss Francs.
This was the fourth straight year of sales growth at Santhera Pharmaceuticals Holding AG.